Investor Details
| Filer Name: | ROSALIND ADVISORS, INC. |
|---|---|
| CIK: | 1622627 |
| Period: | 2024-12-31 |
| Filed At: | 2025-02-11 |
| Number of Holdings: | 40 |
| Portfolio Value: | $0.20B |
Rosalind Advisors, Inc. Top Holdings
| Ticker | Exchange | Security | Shares | Value | % of Portfolio | Position Change | Put/Call |
|---|---|---|---|---|---|---|---|
| DCTH | US | DELCATH SYSTEMS INC | 2,650,389 | $32M | 16.32% | - | - |
| MYO | US | MYOMO INC | 2,998,945 | $19M | 9.87% | -0.7% | - |
| MDWD | US | MEDIWOUND LTD | 628,050 | $11M | 5.72% | - | - |
| CMRX | US | CHIMERIX INC | 3,050,000 | $11M | 5.43% | 100.0% | - |
| XERS | US | XERIS BIOPHARMA HOLDINGS INC | 3,104,995 | $11M | 5.38% | - | - |
| ABEO | US | ABEONA THERAPEUTICS INC | 1,805,390 | $10M | 5.14% | -1.5% | - |
| OCUL | US | OCULAR THERAPEUTIX INC | 1,128,700 | $10M | 4.93% | 27.5% | - |
| URGN | US | UROGEN PHARMA LTD | 870,000 | $9M | 4.74% | 100.0% | - |
| SVRA | US | SAVARA INC | 2,654,944 | $8M | 4.17% | 100.0% | - |
| FENC | US | FENNEC PHARMACEUTICALS INC | 1,259,876 | $8M | 4.07% | 100.0% | - |
| CYBN | US | CYBIN INC | 810,918 | $7M | 3.66% | 100.0% | - |
| VRNA | US | VERONA PHARMA PLC - ADR | 150,000 | $7M | 3.56% | -45.5% | - |
| NSPR | US | INSPIREMD INC | 2,495,783 | $7M | 3.36% | -0.7% | - |
| 68404V209 | - | OPTINOSE INC | 876,996 | $6M | 3.00% | 100.0% | - |
| PROF | US | PROFOUND MEDICAL CORP | 692,185 | $5M | 2.66% | 42.4% | - |
| VSTM | US | VERASTEM INC | 900,000 | $5M | 2.38% | 100.0% | - |
| TRVI | US | TREVI THERAPEUTICS INC | 1,062,500 | $4M | 2.24% | 41.7% | - |
| 14817C957 | - | CASSAVA SCIENCES INC | 417,400 | $4M | 1.87% | 13.6% | Put |
| REPL | US | REPLIMUNE GROUP INC | 260,000 | $3M | 1.61% | 100.0% | - |
| PYPD | US | POLYPID LTD | 1,022,521 | $3M | 1.59% | 50.6% | - |